Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Shuermaikang Pharmaceutical Co., Ltd. (also known as Hubei Shure Matcon Pharmaceutical) is a pharmaceutical manufacturing company based in Jingzhou, Hubei Province, China. As a wholly-owned subsidiary of Asia De'an Group, the company specializes in the research, development, and production of external-use topical preparations, including medicated plasters and creams. Its product portfolio features traditional Chinese medicine pain-relief plasters such as Huoxue Pain Relief Ointment and Musk Zhuanggu Plaster, as well as dermatological creams like Compound Ketoconazole Cream and Clobetasol Propionate Cream. The company operates a GMP-certified manufacturing facility in the Guanyinzhai Industrial Park to supply over-the-counter and prescription topical treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Shuermaikang Pharmaceutical.